生分解性医薬品包装の世界市場：材料別、製品タイプ別、エンドユーザー別、用途別、地域範囲別および予測

生分解性医薬品包装の市場規模と予測

生分解性医薬品包装の市場規模は、2024年に705億米ドルと評価され、2026～2032年にかけて16.2%のCAGRで成長し、2032年には2,211億7,000万米ドルに達すると予測されます。

生分解性医薬品包装には、自然に分解される医薬品用の材料とソリューションが含まれ、環境への害を最小限に抑えながら、消費者に安全かつ効果的に医薬品を封じ込めることができます。この包装カテゴリには、植物由来のプラスチック、再生紙、生分解性ポリマーなどさまざまな材料が含まれ、医薬品の有効性と安全性を確保しながら環境への影響を低減するように設計されています。生分解性医薬品包装の将来は、先進バイオ材料、革新的なスマート包装技術、循環経済モデルの開発に焦点を当て、製薬産業における持続可能性をさらに高め、環境への責任を促進します。

生分解性医薬品包装の世界市場力学

世界の生分解性医薬品包装市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

環境問題への関心の高まり：環境問題への関心の高まり：プラスチック汚染と環境の持続可能性に対する意識の高まりは、製薬会社が生分解性包装ソリューションを採用する動機付けとなっており、それによって市場の成長が著しく促進され、世界の生態学的課題に対処しています。

課題に取り組んでいます。

厳しい規制：サステイナブル実践を推進し、使い捨てプラスチックの使用を制限する政府の規制は、製薬産業に生分解性包装代替品への移行を迫っており、コンプライアンスと環境責任を強化しています。

消費者の嗜好：エコフレンドリー製品に対する消費者の需要の高まりは、製薬会社に生分解性包装の採用を促し、ブランドイメージを向上させ、持続可能性を重視する市場での競合を増加させています。生分解性材料と製造プロセスの革新により、生分解性医薬品包装の性能と費用対効果が向上しているため、産業全体での採用が加速し、サステイナブルプラクティスが促進されています。

主要課題

コストの制約：生分解性材料は従来型プラスチックに比べて製造コストが高いため、普及の妨げとなる可能性があります。

性能に関する懸念：生分解性包装の大きな課題は、従来型包装と同レベルの医薬品の保護、安定性、保存性を確保し、有効性と安全性の基準を維持することです。

主要動向

バイオベースプラスチック：トウモロコシのデンプンやサトウキビのような再生可能資源を原料とするバイオベースプラスチックの開発と採用が、医薬品包装用途で牽引力を増しています。スマートな生分解性包装：スマート技術と生分解性材料との融合により、薬剤の状態をモニターし、リアルタイムで情報を提供できる包装が重要な動向として浮上しています。

循環型経済への取り組み：製薬会社は、廃棄物や環境への影響を最小限に抑えるため、リサイクル可能で堆肥化可能な包装ソリューションに重点を置き、循環型経済の原則を採用する傾向が強まっています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主要調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 生分解性医薬品包装市場：材料別

• プラスチック
• 紙・板紙
• ガラス
• その他

第5章 生分解性医薬品包装市場：製品タイプ別

• ボトル
• ブリスターパック
• バイアル・アンプル
• パウチ・小袋
• その他

第6章 生分解性医薬品包装市場：エンドユーザー別

• 医薬品メーカー
• 受託包装会社
• 小売薬局
• その他

第7章 生分解性医薬品包装市場：用途別

• 経口医薬品
• 注射剤
• 外用薬
• その他

第8章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第9章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第10章 競合情勢

• 主要企業
• 市場シェア分析

第11章 企業プロファイル

• Gerresheimer AG
• Berry Global Inc.
• Amcor plc
• Becton
• Dickinson and Company
• West Pharmaceutical Services Inc.
• Eastman Chemical Company
• Schott AG
• AptarGroup Inc.
• Nipro Corporation and CCL Industries Inc.

第12章 市場展望市場展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第13章 付録

• 略語リスト
• 供給源と参考文献

Biodegradable Pharmaceutical Packaging Market Size and Forecast

Biodegradable Pharmaceutical Packaging Market size was valued at USD 70.5 Billion in 2024 and is projected to reach USD 221.17 Billion by 2032 growing at a CAGR of 16.2% from 2026 to 2032.

Biodegradable pharmaceutical packaging includes materials and solutions for drug products that naturally decompose, minimizing environmental harm while ensuring safe and effective containment of pharmaceuticals for consumers.This packaging category encompasses various materials, such as plant-based plastics, recycled paper and biodegradable polymers, all designed to reduce environmental impact while ensuring the efficacy and safety of pharmaceutical products.The future of biodegradable pharmaceutical packaging focuses on developing advanced biomaterials, innovative smart packaging technologies and circular economy models to further enhance sustainability within the pharmaceutical industry and promote environmental responsibility.

Global Biodegradable Pharmaceutical Packaging Market Dynamics

The key market dynamics that are shaping the global biodegradable pharmaceutical packaging market include:

Key Market Drivers:

Growing Environmental Concerns: Increasing awareness of plastic pollution and environmental sustainability is motivating pharmaceutical companies to adopt biodegradable packaging solutions, thereby significantly boosting market growth and addressing global ecological

challenges.

Stringent Regulations: Government regulations promoting sustainable practices and restricting the use of single-use plastics are compelling the pharmaceutical industry to transition toward biodegradable packaging alternatives, enhancing compliance and environmental responsibility.

Consumer Preference: The rising consumer demand for eco-friendly products is prompting pharmaceutical companies to adopt biodegradable packaging options, improving their brand image and increasing competitiveness in a sustainability-conscious market.Technological Advancements: Innovations in biodegradable materials and manufacturing processes are enhancing the performance and cost-effectiveness of biodegradable pharmaceutical packaging, thereby accelerating its adoption across the industry and fostering sustainable practices.

Key Challenges:

Cost Constraints: The higher production costs associated with biodegradable materials compared to traditional plastics can hinder widespread adoption, especially in price-sensitive markets where affordability is a key consideration for companies.

Performance Concerns: A significant challenge for biodegradable packaging is ensuring it provides the same level of protection, stability and shelf life for pharmaceutical products as conventional packaging, maintaining efficacy and safety standards.

Key Trends:

Bio-based Plastics: The development and adoption of bio-based plastics derived from renewable resources like corn starch or sugarcane are gaining traction in pharmaceutical packaging applications.Smart Biodegradable Packaging: Integration of smart technologies with biodegradable materials to create packaging that can monitor drug conditions and provide real-time information is emerging as a key trend.

Circular Economy Initiatives: Pharmaceutical companies are increasingly adopting circular economy principles, focusing on recyclable and compostable packaging solutions to minimize waste and environmental impact.

Global Biodegradable Pharmaceutical Packaging Market Regional Analysis

Here is a more detailed regional analysis of the global biodegradable pharmaceutical packaging market:

Europe:

According to Verified Market Research, Europe is expected to dominate the Global biodegradable pharmaceutical packaging market. The region benefits from stringent environmental regulations, high environmental awareness and strong government support for sustainable practices, driving its market dominance in the sector.

Presence of major pharmaceutical companies and packaging manufacturers with a focus on sustainability contributes to the region's leading position.The growing emphasis on circular economy principles and extended producer responsibility in Europe supports the adoption of biodegradable packaging solutions.Increasing investments in R&D for bio-based materials and collaborations between material science companies and pharmaceutical firms fuel innovation in the region.

Asia-Pacific:

According to Verified Market Research, Asia-Pacific is the fastest growing region in Global biodegradable pharmaceutical packaging market. The region is experiencing rapid growth in its pharmaceutical industry, coupled with increasing environmental concerns, creating significant demand for sustainable packaging solutions.Rising disposable incomes, growing healthcare expenditure and increasing awareness about environmental issues in countries like China and India drive market growth.Government initiatives to reduce plastic waste and promote sustainable practices in several Asian countries contribute to the rapid adoption of biodegradable packaging.The large manufacturing base and increasing focus on developing cost-effective biodegradable materials in the region support swift market expansion.

Global Biodegradable Pharmaceutical Packaging Market: Segmentation Analysis

The Global Biodegradable Pharmaceutical Packaging Market is segmented on the basis of Material, Product Type, End User, Application and Geography.

Biodegradable Pharmaceutical Packaging Market, By Material

• Plastics
• Paper & Paperboard
• Glass
• Others

Based on Material, the Biodegradable Pharmaceutical Packaging market is segmented into Plastics, Paper & Paperboard, Glass and Others. Plastics are the most dominating material segment, driven by their versatility, lightweight properties and advancements in biodegradable polymer technologies. The increasing development of bio-based and compostable plastics that can meet the stringent requirements of pharmaceutical packaging, coupled with their potential to significantly reduce carbon footprint, contributes significantly to their market dominance.

Biodegradable Pharmaceutical Packaging Market, By Product Type

• Bottles
• Blister Packs
• Vials & Ampoules
• Pouches & Sachets
• Others

Based on Product Type, the Biodegradable Pharmaceutical Packaging market is categorized into Bottles, Blister Packs, Vials & Ampoules, Pouches & Sachets and Others. Bottles are the most dominating product type, driven by their wide usage across various pharmaceutical applications, from liquid medications to solid dosage forms. The ease of incorporating biodegradable materials into bottle manufacturing, along with consumer familiarity and convenience, supports the dominance of bottles in the biodegradable pharmaceutical packaging market.

Biodegradable Pharmaceutical Packaging Market, By End-User

• Pharmaceutical Manufacturers
• Contract Packaging Companies
• Retail Pharmacies
• Others

Based on End User, the Biodegradable Pharmaceutical Packaging market is segmented into Pharmaceutical Manufacturers, Contract Packaging Companies, Retail Pharmacies and Others. Pharmaceutical Manufacturers is the most dominating end-user segment, driven by the direct control they have over packaging decisions and their increasing commitment to sustainability goals. The growing pressure on pharmaceutical companies to reduce their environmental impact and enhance their corporate social responsibility contributes significantly to the dominance of this segment.

Biodegradable Pharmaceutical Packaging Market, By Application

• Oral Drugs
• Injectable
• Topical Medications
• Others

Based on Application, the Biodegradable Pharmaceutical Packaging market is segmented into Oral Drugs, Injectable, Topical Medications and Others. Oral Drugs are the most dominating application segment, driven by the high volume of oral medications in the pharmaceutical market and the relative ease of adapting biodegradable packaging for these products. The wide range of oral drug formats, from tablets to liquids and the frequent use of bottles and blister packs that can be made biodegradable, support their significant market share and dominance in the biodegradable pharmaceutical packaging ecosystem.

Biodegradable Pharmaceutical Packaging Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Based on Geography, the Biodegradable Pharmaceutical Packaging market is segmented into Europe, North America, Asia-Pacific, Latin America and the Middle East & Africa. Europe is both the largest and one of the fastest-growing regions, driven by stringent environmental regulations, high consumer awareness and strong government support for sustainable practices. The region's robust pharmaceutical industry, coupled with its leadership in circular economy initiatives and bio-based material development, contributes significantly to its market dominance and continued rapid growth.

Key Players

• The Global Biodegradable Pharmaceutical Packaging Market study report will provide valuable insight with an emphasis on the global market. The major players in the Biodegradable Pharmaceutical Packaging Market include Gerresheimer AG, Berry Global Inc., Amcor plc, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Eastman Chemical Company, Schott AG, AptarGroup, Inc., Nipro Corporation and CCL Industries Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

• Biodegradable Pharmaceutical Packaging Market Recent Developments
• In February 2024, Gerresheimer AG launched a new line of fully biodegradable plastic bottles for liquid medications, made from plant-based materials that can decompose in industrial composting facilities within 6 months. In April 2024, Amcor plc announced a partnership with a leading biotechnology firm to develop a novel biodegradable polymer specifically designed for blister packaging of moisture-sensitive drugs, aiming to replace traditional aluminum-plastic combinations.

TABLE OF CONTENTS

1. INTRODUCTION

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Biodegradable Pharmaceutical Packaging Market, By Material

• Plastics
• Paper & Paperboard
• Glass
• Others

5. Biodegradable Pharmaceutical Packaging Market, By Product Type

• Bottles
• Blister Packs
• Vials & Ampoules
• Pouches & Sachets
• Others

6. Biodegradable Pharmaceutical Packaging Market, By End-User

• Pharmaceutical Manufacturers
• Contract Packaging Companies
• Retail Pharmacies
• Others

7. Biodegradable Pharmaceutical Packaging Market, By Application

• Oral Drugs
• Injectable
• Topical Medications
• Others

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• Gerresheimer AG
• Berry Global Inc.
• Amcor plc
• Becton
• Dickinson and Company
• West Pharmaceutical Services Inc.
• Eastman Chemical Company
• Schott AG
• AptarGroup Inc.
• Nipro Corporation and CCL Industries Inc.

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References